1 active not recruiting, 1 completed, 1 recruiting. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
Follow Oligometastatic Renal Cell Carcinoma: new trials by email Literature Review of Oligometastatic Renal Cell Carcinoma trials Research Report on Oligometastatic Renal Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs) Pembrolizumab, Radiation therapy - Oligometastatic Renal Cell Carcinoma | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 144 | 2023-10-31 | 2026-07-16 |
| Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer Pembrolizumab injection plus metastasis directed treatment (surgery or RT), Tumor resection or RT - Oligometastatic Renal Cell Carcinoma | Phase 2 | Active not recruiting | Consorzio Oncotech | 85 | 2023-03-14 | 2026-10-21 |
| SAbR For Oligometastatic Renal Cell Carcinoma Stereotactic ablative body radiation (SABR) - Oligometastatic Renal Cell Carcinoma | Not applicable | Completed | University of Texas Southwestern Medical Center | 23 | 2018-07-19 | 2026-08-31 |
pembrolizumab (2) · Radiotherapy (1) · Surgical Procedures, Operative (1)
Consorzio Oncotech (1) · M.D. Anderson Cancer Center (1) · University of Texas Southwestern Medical Center (1)
United States (2) · Italy (1)
Chad Tang, MD (1) · Raquibul Hannan, MD, PhD (1) · Roberto Iacovelli, MD, PhD (1)